---
schema_version: "secwatch.filing_event.v1"
accession: "0001140361-24-025326"
form_type: "8-K"
ticker: "SNWV"
cik: "0001417663"
company_name: "SANUWAVE Health, Inc."
filed_at: "2024-05-10T23:59:59+00:00"
generated_at: "2026-06-02T03:31:44.942957+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# SANUWAVE Q1 revenue up 53% to $5.8M; operating loss narrows to $1.1M; reaffirms FY 2024 growth guidance of 50%

## Summary
- Revenue $5.8M (+53% YoY); gross margin 73% (+600bps); UltraMist consumables revenue $4.1M (+64%).
- Operating loss $1.1M vs $2.0M in Q1 2023; net loss $4.5M includes $3.9M non-cash derivative charge.
- Adjusted EBITDA loss improved to $59K from $1.8M loss YoY.
- Guidance: Q2 2024 revenue growth 45-55% YoY; FY 2024 revenue growth of 50% reiterated.
- Sold 43 UltraMist systems in Q1 (up from 28 in Q1 2023, down from 79 in Q4 2023).

## SEC filing metadata
- accession: 0001140361-24-025326
- form_type: 8-K
- ticker: SNWV
- cik: 0001417663
- company_name: SANUWAVE Health, Inc.
- filed_at: 2024-05-10T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1417663/000114036124025326/0001140361-24-025326-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1417663/000114036124025326/ef20028815_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001140361-24-025326
- JSON: https://secwatch.observer/filing/0001140361-24-025326.json
- Plain text: https://secwatch.observer/filing/0001140361-24-025326.txt

## Key facts
- Earnings Releases
  SANUWAVE Health, Inc. reported first quarter ended March 31, 2024 results: revenue $5.8 million, net income $4.5 million. Guidance reaffirmed.
  - Period: first quarter ended March 31, 2024
  - Revenue: $5.8 million
  - Net income: $4.5 million
  - Guidance: reaffirmed
  - Result: reported results
  source text: in such filing. --- EX-99.1 (EXHIBIT 99.1) --- EX-99.1 2 ef20028815_99-1.htm EXHIBIT 99.1 Exhibit 99.1 SANUWAVE Announces Q1 FY2024 Financial Results Q1 2024 revenues were $5.8 million, up 53% from Q1 2023 Q1 2024 gross margin was 73%, up 600bp from Q1 2023 Operating loss was $1.1 million for Q1 2024 compared to $2.0 million for Q1 2023 Company provides
  evidence_url: https://www.sec.gov/Archives/edgar/data/1417663/000114036124025326/0001140361-24-025326-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.